InsideArbitrage Event Driven Monitor – August 23, 2023

Subscribe to receive our Event Driven Monitor by email every morning before the market opens.

Merger Arbitrage

1. RETA: Reata Pharmaceuticals announced that the special meeting of shareholders to consider and vote upon a proposal to approve and adopt the agreement and plan of merger with Biogen (BIIB) will be held on September 21, 2023.

Only plus or premium subscribers can access this post. Subscribe today.